SFP
NVO

Santa Fe Partners’s Novo Nordisk NVO Stock Holding History

Santa Fe Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-86,692
Closed -$2.35M – 545
2015
Q3 		$2.35M Buy
+86,692
New +$2.45M 0.31% 125
2013
Q4 		– Sell
-25,940
Closed -$439K – 543
2013
Q3 		$439K Sell
25,940
-43,260
-63% -$728K 0.08% 327
2013
Q2 		$1.07M Buy
+69,200
New +$1.15M 0.22% 188

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Santa Fe Partners's NVO Position: Q4 2015 in Review

Santa Fe Partners sold out of Novo Nordisk (NVO) in Q4 2015, closing a stake of 86,692 shares — an estimated $2.35M sold.

Santa Fe Partners first reported a position in NVO in Q2 2013 and held it in 3 quarters. The position peaked at $2.35M in Q3 2015. 548 funds tracked by Wall St. Rank hold NVO as of Q4 2015.

  • Santa Fe Partners reported no remaining Novo Nordisk position as of Q4 2015 after selling out during the quarter.
  • Santa Fe Partners sold 86,692 Novo Nordisk shares in Q4 2015, an estimated $2.35M.
  • Santa Fe Partners first reported a position in Novo Nordisk in Q2 2013 and held it in 3 quarters.
  • Santa Fe Partners's Novo Nordisk position peaked at $2.35M in Q3 2015.
  • 548 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2015.

Based on Santa Fe Partners's 13F filing for Q4 2015, filed 12 Feb 2016.